Other reported results [78, 80–85] also suggest that CK-18 can be a potentially useful biomarker for the diagnosis and differentiation of NASH from simple hepatosteatosis. The gene discussed is KRT18; the disease is metabolic dysfunction-associated steatohepatitis.